• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
72,467.78 3,292.81
(4.76%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.55 -0.19
(-0.20%)
EUR-INR
107.36 -0.64
(-0.59%)
GBP-INR
124.56 -0.65
(-0.52%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
19.72
133.1
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.44
 

Rolex Rings reports standalone net loss of Rs 0.15 crore in the March 2026 quarter
May 16,2026
Net loss of Rolex Rings reported to Rs 0.15 crore in the quarter ended March 2026 as against net profit of Rs 54.64 crore during the previous quarter ended March 2025. Sales rose 7.68% to Rs 305.69 crore in the quarter ended March 2026 as against Rs 283.89 crore during the previous quarter ended March 2025.

For the full year,net profit declined 18.91% to Rs 141.10 crore in the year ended March 2026 as against Rs 174.00 crore during the previous year ended March 2025. Sales declined 0.98% to Rs 1143.50 crore in the year ended March 2026 as against Rs 1154.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales305.69283.89 8 1143.501154.80 -1
OPM %18.4018.39 -20.1420.84 -
PBDT58.7560.96 -4 279.06266.72 5
PBT49.3749.32 0 241.93226.30 7
NP-0.1554.64 PL 141.10174.00 -19